Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were...
from NDTV News - Latest https://ift.tt/2Zh3nZ8
Saturday, July 11, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment